Pathogenesis of influenza virus infections: The good, the bad and the ugly, Curr. Opin. Virol, vol.2, pp.276-286, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-01595054
Influenza: Emergence and control, J. Virol, vol.78, pp.8951-8959, 2004. ,
Switch from protective to adverse inflammation during influenza: Viral determinants and hemostasis are caught as culprits, Cell. Mol. Life Sci. CMLS, vol.71, pp.885-898, 2014. ,
Receptor binding properties of the influenza virus hemagglutinin as a determinant of host range, Curr. Top. Microb. Immunol, vol.385, pp.63-91, 2014. ,
A review of influenza haemagglutinin receptor binding as it relates to pandemic properties, vol.30, pp.4369-4376, 2012. ,
Entry of influenza virus, Adv. Exp. Med. Biol, vol.790, pp.72-82, 2013. ,
Transport of the influenza virus genome from nucleus to nucleus, vol.5, pp.2424-2446, 2013. ,
Influenza A: Understanding the viral life cycle, Yale J. Biol. Med, vol.82, pp.153-159, 2009. ,
Influenza virus morphogenesis and budding, Virus Res, vol.143, pp.147-161, 2009. ,
Annexin II incorporated into influenza virus particles supports virus replication by converting plasminogen into plasmin, J. Virol, vol.82, pp.6820-6828, 2008. ,
Annexin V incorporated into influenza virus particles inhibits gamma interferon signaling and promotes viral replication, J. Virol, vol.88, pp.11215-11228, 2014. ,
Formyl Peptide Receptor 2 Plays a Deleterious Role During Influenza A Virus Infections, J. Infect. Dis, vol.214, pp.237-247, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01478131
Cellular proteins in influenza virus particles, PLoS Pathog, 2008. ,
Antiviral activity of formyl peptide receptor 2 antagonists against influenza viruses, Antivir. Res, vol.143, pp.252-261, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01755130
Influenza A virus-induced early activation of ERK and PI3K mediates V-ATPase-dependent intracellular pH change required for fusion, Cell. Microbiol, vol.13, pp.587-601, 2011. ,
Influenza virus propagation is impaired by inhibition of the Raf/MEK/ERK signalling cascade, Nat. Cell Boil, vol.3, pp.301-305, 2001. ,
Identification of peptides that antagonize formyl peptide receptor-like 1-mediated signaling, J. Immunol, vol.173, pp.607-614, 2004. ,
The influenza virus nucleoprotein: A multifunctional RNA-binding protein pivotal to virus replication, J. Gen. Virol, vol.83, issue.4, pp.723-734, 2002. ,
Antibody-based therapies for emerging infectious diseases, Emerg. Infect. Dis, vol.2, pp.200-208, 1996. ,
Resolvin D1 limits polymorphonuclear leukocyte recruitment to inflammatory loci: Receptor-dependent actions, Arterioscler. Thromb. Vasc. Biol, vol.32, 1970. ,
Invariant NKT cells modulate the suppressive activity of IL-10-secreting neutrophils differentiated with serum amyloid A, Nat. Immunol, vol.11, pp.1039-1046, 2010. ,
FPR2: A Novel Promising Target for the Treatment of Influenza. Front, 1719. ,
URL : https://hal.archives-ouvertes.fr/hal-01744140
Influenza A virus enhances its propagation through the modulation of Annexin-A1 dependent endosomal trafficking and apoptosis, Cell Death Differ, vol.23, pp.1243-1256, 2016. ,
Annexins-Unique membrane binding proteins with diverse functions, J. Cell Sci, vol.13, pp.2631-2639, 2004. ,
Annexins-scaffolds modulating PKC localization and signaling, Cell. Signal, vol.26, pp.1213-1225, 2014. ,
Highlight: Annexins in health and disease, Biol. Chem, vol.397, pp.947-948, 2016. ,
Plasminogen promotes influenza A virus replication through an annexin 2-dependent pathway in the absence of neuraminidase, J. Gen. Virol, vol.11, pp.2753-2761, 2010. ,
Annexin A2 (ANXA2) interacts with nonstructural protein 1 and promotes the replication of highly pathogenic H5N1 avian influenza virus, BMC Microbiol, vol.17, 0191. ,
Involvement of annexin V in the entry of influenza viruses and role of phospholipids in infection, FEBS Lett, vol.392, pp.59-62, 1996. ,
Annexin A6-balanced late endosomal cholesterol controls influenza A replication and propagation, MBio, vol.4, pp.608-621, 2013. ,
Human annexin A6 interacts with influenza a virus protein M2 and negatively modulates infection, J. Virol, vol.86, pp.1789-1801, 2012. ,
URL : https://hal.archives-ouvertes.fr/pasteur-00645399
Emerging functions as host cell factors-An encyclopedia of annexin-pathogen interactions, Biol. Chem, vol.397, pp.949-959, 2016. ,
Role of annexin A2 in the production of infectious hepatitis C virus particles, J. Virol, vol.84, pp.5775-5789, 2010. ,
Annexin 2-mediated enhancement of cytomegalovirus infection opposes inhibition by annexin 1 or annexin 5, J. Gen. Virol, vol.88, issue.1, pp.19-27, 2007. ,
Comparison of the mutation rates of human influenza A and B viruses, J. Virol, vol.80, pp.3675-3678, 2006. ,
Influenza virus resistance to antiviral agents: A plea for rational use, Clin. Infect. Dis, vol.48, pp.1254-1256, 2009. ,
Disruption of virus-host cell interactions and cell signaling pathways as an anti-viral approach against influenza virus infections, Biol. Chem, vol.392, pp.837-847, 2011. ,
Development of cellular signaling pathway inhibitors as new antivirals against influenza, Antivir. Res, vol.98, pp.457-468, 2013. ,
Targeting cell signalling pathways to fight the flu: Towards a paradigm change in anti-influenza therapy, J. Antimicrob. Chemother, vol.64, pp.1-4, 2009. ,
Targeting intracellular signaling as an antiviral strategy: Aerosolized LASAG for the treatment of influenza in hospitalized patients, Emerg. Microbes Infect, 2018. ,
The MEK-inhibitor CI-1040 displays a broad anti-influenza virus activity in vitro and provides a prolonged treatment window compared to standard of care in vivo, Antivir. Res, vol.142, pp.178-184, 2017. ,
Potent antibody therapeutics by design, Nat. Rev. Immunol, vol.6, pp.343-357, 2006. ,